![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
HIV Post-exposure Prophylaxis (PEP) Prescription
Trends (underutilized) - United States, 2013-2022
|
|
|
CROI 2024 March 3-6 Denver
Mary R. Tanner, Wei Wei, Weiming Zhu, Ya-lin A. Huang, Jesse O’Shea, Athena P. Kourtis, Karen W. Hoover
HIV Research Branch, Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA
![0327241](../images/032724/032724-2/0327241.gif)
![0327242](../images/032724/032724-2/0327242.gif)
![0327243](../images/032724/032724-2/0327243.gif)
![0327244](../images/032724/032724-2/0327244.gif)
![0327245](../images/032724/032724-2/0327245.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|